The effect was smaller among females, Asian, Black, and Hispanic race, and patients with lower incomes.
The company expects an FDA decision in the first quarter of 2024.
Longer transmission seasons and migration of mosquitoes to new latitudes threaten to undo years of progress.
Patient blood samples showed signs of persistent immune-system changes believed to be related to long COVID.
Risk factors for long or very long COVID included female sex, the presence of least one underlying condition, and moderate or severe COVID-19.
Interviews with sick patients and trace-back investigation pointed to a specific diced onion producer.
The study was based on outcomes seen among 660,000 UK patients from February 2020 to April 2021.
Relative vaccine effectiveness was an additional 50% against critical illness.
While antibiotic use at three Chicago hospitals increased in COVID-19 patients at the outset of the pandemic, it declined among non–COVID patients.
The roadmap aims to help countries in the region identify, prioritize, implement, and monitor high-impact interventions to address AMR across the One Health spectrum.
With the exact source still murky and investigations still under way, officials expect more cases.
The FDA last week approved Pfizer's new vaccine, called Penbraya, which covers five serogroups.
Thirty-day death rates were 8% in the Omicron group, 3% in flu patients, and 6% in the RSV group.
In influenza news, US flu cases appear to be rising, and officials have confirmed more avian flu outbreaks in US poultry.
Formulations of the combo vaccines prompted robust immune responses against influenza A, influenza B, and SARS-CoV-2.
The researchers estimated 1 in 30 hospitalizations among newly infected adults aged 80 years and older.
The analysis included 806 patients who were infected with the wild-type strain, Alpha, Delta, or Omicron strain.
Testing during inspection revealed positive microbiological samples in the facility's key production areas.
The estimated percentage of JN.1 viruses is very small—about 0.1%.
The study suggests the seasonal flu vaccine could be a tool to help address rising antibiotic resistance.
No effect was seen on women's or men's vaccination status and miscarriage rates.
The only benefit seen was a lowered combined risk for venous thromboembolism.
A total of 39% to 54% reported no change in these behaviors, and less than 1% reported an increase.
Influenza A is most common, with H3N2 seen in about two-thirds of subtyped samples.
The reports include an outbreak at a large Alabama gamebird farm.
